Stay updated on Setmelanotide in BBS and AS for Obesity Clinical Trial

Sign up to get notified when there's something new on the Setmelanotide in BBS and AS for Obesity Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Setmelanotide in BBS and AS for Obesity Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study record for setmelanotide in participants with Bardet-Biedl or Alström syndrome is available, including its design, eligibility criteria, outcome measures, locations, and posted results. It also includes study documents and record-history details.
    Difference
    62%
    Check dated 2026-11-09T13:40:18.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label updates from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:42:31.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A sitewide notice announces that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a terminology transition.
    Difference
    1%
    Check dated 2026-10-26T14:12:31.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2, while the study page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:36:47.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the access-denied page.
    Difference
    0.2%
    Check dated 2026-10-12T14:43:51.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a simple header and a Home button, replacing the study content and indicating access restrictions. This prevents users from viewing the study record and related information.
    Difference
    19%
    Check dated 2026-09-21T22:01:09.000Z thumbnail image

Stay in the know with updates to Setmelanotide in BBS and AS for Obesity Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Setmelanotide in BBS and AS for Obesity Clinical Trial page.